ArticleNutrition journal2026
Long-chain omega-3-enriched erythrocyte fatty acid pattern is associated with lower odds of obesity and metabolic dysfunction-associated steatotic liver disease.
Article in Nutrition journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundErythrocyte membrane fatty acids (FAs) reflect medium-term FA status and may capture integrated metabolic profiles beyond individual FAs. Their relationships with obesity and metabolic dysfunction-associated steatotic liver disease (MASLD) remain insufficiently characterized.
methodsWe analyzed nationally representative U.S. adults with available erythrocyte FA measurements. Principal component analysis (PCA) was applied to 21 FAs, and the first five components were retained. Survey-weighted regression models evaluated associations of principal component (PC) scores with body weight status and MASLD defined by vibration-controlled transient elastography and cardiometabolic criteria. Pearson correlations assessed relationships between PC scores and energy-adjusted dietary FA intake. False discovery rate (FDR) correction was applied.
resultsAmong 4,979 adults, a long-chain omega-3-enriched pattern (PC2) was independently associated with lower odds of obesity (OR per 1-SD increase 0.74; 95% CI 0.68-0.81; q < 0.001) and was modestly correlated with higher dietary long-chain omega-3 intake (r = 0.22). Among 3,448 participants with valid elastography data, PC2 was similarly associated with lower odds of MASLD (OR per 1-SD increase 0.73; 95% CI 0.67-0.80; q < 0.001). PC3, characterized by higher eicosadienoic acid, gondoic acid, and linoleic acid, was also inversely associated with both obesity and MASLD.
conclusionIn this cross-sectional study of U.S. adults, a long-chain omega-3-enriched erythrocyte FA pattern was associated with 26% lower odds of obesity and 27% lower odds of MASLD. These findings suggest that erythrocyte FA patterns may reflect integrated dietary and metabolic FA status associated with obesity and MASLD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.